HIV/AIDS患者停药影响因素的研究进展

Dong Wen-yi, Xie Zhi-man
{"title":"HIV/AIDS患者停药影响因素的研究进展","authors":"Dong Wen-yi, Xie Zhi-man","doi":"10.13604/J.CNKI.46-1064/R.2021.02.20","DOIUrl":null,"url":null,"abstract":"AIDS is a highly harmful infectious disease caused by human immunodeficiency virus (HIV), which requires HIV/AIDS patients to take medication on time and at the appropriate amount every day to effectively inhibit HIV replication in vivo. China has implemented antiretroviral therapy (ART) and expanded treatment strategy, including all eligible HIV-infected people into the treatment scope of treatment. More and more HIV-infected patients receive ART. At the same time, the number of HIV/AIDS patients who withdraw from ART (drug withdrawal and loss of follow-up) is also increasing year by year. In the long-term medication process of HIV/AIDS patients, various reasons such as adverse drug reactions, busy work, CD4, low selfmanagement ability of patients, economic conditions and other reasons lead to poor compliance of patients and high incidence of withdrawal. In China, ART treatment coverage of HIV/AIDS patients is required to be over 90%, and withdrawal has become the biggest threat to the coverage of ART treatment. In this paper, the influencing factors related to ART withdrawal of HIV/ AIDS patients were summarized to comprehensively understand the reasons for the possible withdrawal of ART therapy for HIV/ AIDS patients, and to provide measures to reduce the withdrawal and loss of follow-up of ART therapy for HIV/AIDS patients. 摘要 : 艾滋病是由人类免疫缺陷病毒(HIV)引起的一种危害性极大的传染病, 需要 HIV/AIDS 患者每日按时按量服 药才能有效抑制体内 HIV 复制。中国实施抗逆转录病毒疗法(ART)和扩大治疗策略将所有符合条件的 HIV 感染者纳人 治疗范围, 越来越多的 HIV 感染者接受ART,同时退出 (停药和失访)ART的 HIV/AIDS 患者人数也在逐年累加。在 HIV/AIDS 患者长期的服药过程中, 药物不良反应、工作繁忙、CD4、患者自我管理能力低、经济条件等各种原因, 导致患 者出现依从性不良 , 患者退出的发生率髙。中国遏制与防治艾滋病要求 HIV/AIDS 患者 ART 治疗覆盖率是90%以上, 退出已经成为影响ART治疗覆盖率的最大威胁。本文就 HIV/AIDS 患者 ART 退出相关影响因素进行综述, 全面了解 HIV/AIDS 患者ART治疗可能退出的原因以及提供减少 HIV/AIDS 患者ART治疗停药和失访相关措施。","PeriodicalId":10045,"journal":{"name":"中国热带医学","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research progress on influencing factors of antiretroviral therapy withdrawal in HIV/AIDS patients\",\"authors\":\"Dong Wen-yi, Xie Zhi-man\",\"doi\":\"10.13604/J.CNKI.46-1064/R.2021.02.20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"AIDS is a highly harmful infectious disease caused by human immunodeficiency virus (HIV), which requires HIV/AIDS patients to take medication on time and at the appropriate amount every day to effectively inhibit HIV replication in vivo. China has implemented antiretroviral therapy (ART) and expanded treatment strategy, including all eligible HIV-infected people into the treatment scope of treatment. More and more HIV-infected patients receive ART. At the same time, the number of HIV/AIDS patients who withdraw from ART (drug withdrawal and loss of follow-up) is also increasing year by year. In the long-term medication process of HIV/AIDS patients, various reasons such as adverse drug reactions, busy work, CD4, low selfmanagement ability of patients, economic conditions and other reasons lead to poor compliance of patients and high incidence of withdrawal. In China, ART treatment coverage of HIV/AIDS patients is required to be over 90%, and withdrawal has become the biggest threat to the coverage of ART treatment. In this paper, the influencing factors related to ART withdrawal of HIV/ AIDS patients were summarized to comprehensively understand the reasons for the possible withdrawal of ART therapy for HIV/ AIDS patients, and to provide measures to reduce the withdrawal and loss of follow-up of ART therapy for HIV/AIDS patients. 摘要 : 艾滋病是由人类免疫缺陷病毒(HIV)引起的一种危害性极大的传染病, 需要 HIV/AIDS 患者每日按时按量服 药才能有效抑制体内 HIV 复制。中国实施抗逆转录病毒疗法(ART)和扩大治疗策略将所有符合条件的 HIV 感染者纳人 治疗范围, 越来越多的 HIV 感染者接受ART,同时退出 (停药和失访)ART的 HIV/AIDS 患者人数也在逐年累加。在 HIV/AIDS 患者长期的服药过程中, 药物不良反应、工作繁忙、CD4、患者自我管理能力低、经济条件等各种原因, 导致患 者出现依从性不良 , 患者退出的发生率髙。中国遏制与防治艾滋病要求 HIV/AIDS 患者 ART 治疗覆盖率是90%以上, 退出已经成为影响ART治疗覆盖率的最大威胁。本文就 HIV/AIDS 患者 ART 退出相关影响因素进行综述, 全面了解 HIV/AIDS 患者ART治疗可能退出的原因以及提供减少 HIV/AIDS 患者ART治疗停药和失访相关措施。\",\"PeriodicalId\":10045,\"journal\":{\"name\":\"中国热带医学\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国热带医学\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.13604/J.CNKI.46-1064/R.2021.02.20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国热带医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.13604/J.CNKI.46-1064/R.2021.02.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

艾滋病是由人类免疫缺陷病毒(HIV)引起的高度有害的传染病,需要HIV/AIDS患者每天按时、适量服药,才能有效抑制HIV在体内的复制。中国实施抗逆转录病毒治疗和扩大治疗战略,将所有符合条件的艾滋病毒感染者纳入治疗范围。越来越多的艾滋病毒感染者接受抗逆转录病毒治疗。与此同时,退出抗逆转录病毒治疗(停药和失去随访)的艾滋病毒/艾滋病患者人数也在逐年增加。在HIV/AIDS患者长期用药过程中,药物不良反应、工作繁忙、CD4、患者自我管理能力低、经济条件等多种原因导致患者依从性差,停药发生率高。在中国,HIV/AIDS患者ART治疗覆盖率要求达到90%以上,停药已成为ART治疗覆盖率的最大威胁。本文对影响HIV/AIDS患者停药的相关因素进行总结,全面了解HIV/AIDS患者可能停药的原因,为减少HIV/AIDS患者停药和失去ART治疗的随访提供措施。摘要:艾滋病是由人类免疫缺陷病毒(HIV)引起的一种危害性极大的传染病,需要艾滋病毒/艾滋病患者每日按时按量服药才能有效抑制体内HIV复制。中国实施抗逆转录病毒疗法(ART)和扩大治疗策略将所有符合条件的艾滋病毒感染者纳人治疗范围,越来越多的艾滋病毒感染者接受艺术,同时退出(停药和失访)艺术的艾滋病毒/艾滋病患者人数也在逐年累加。在艾滋病毒/艾滋病患者长期的服药过程中,药物不良反应,工作繁忙,CD4,患者自我管理能力低,经济条件等各种原因,导致患者出现依从性不良,患者退出的发生率髙。中国遏制与防治艾滋病要求艾滋病毒/艾滋病患者艺术治疗覆盖率是90%以上,退出已经成为影响艺术治疗覆盖率的最大威胁。本文就艾滋病毒/艾滋病患者艺术退出相关影响因素进行综述,全面了解艾滋病毒/艾滋病患者艺术治疗可能退出的原因以及提供减少艾滋病毒/艾滋病患者艺术治疗停药和失访相关措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Research progress on influencing factors of antiretroviral therapy withdrawal in HIV/AIDS patients
AIDS is a highly harmful infectious disease caused by human immunodeficiency virus (HIV), which requires HIV/AIDS patients to take medication on time and at the appropriate amount every day to effectively inhibit HIV replication in vivo. China has implemented antiretroviral therapy (ART) and expanded treatment strategy, including all eligible HIV-infected people into the treatment scope of treatment. More and more HIV-infected patients receive ART. At the same time, the number of HIV/AIDS patients who withdraw from ART (drug withdrawal and loss of follow-up) is also increasing year by year. In the long-term medication process of HIV/AIDS patients, various reasons such as adverse drug reactions, busy work, CD4, low selfmanagement ability of patients, economic conditions and other reasons lead to poor compliance of patients and high incidence of withdrawal. In China, ART treatment coverage of HIV/AIDS patients is required to be over 90%, and withdrawal has become the biggest threat to the coverage of ART treatment. In this paper, the influencing factors related to ART withdrawal of HIV/ AIDS patients were summarized to comprehensively understand the reasons for the possible withdrawal of ART therapy for HIV/ AIDS patients, and to provide measures to reduce the withdrawal and loss of follow-up of ART therapy for HIV/AIDS patients. 摘要 : 艾滋病是由人类免疫缺陷病毒(HIV)引起的一种危害性极大的传染病, 需要 HIV/AIDS 患者每日按时按量服 药才能有效抑制体内 HIV 复制。中国实施抗逆转录病毒疗法(ART)和扩大治疗策略将所有符合条件的 HIV 感染者纳人 治疗范围, 越来越多的 HIV 感染者接受ART,同时退出 (停药和失访)ART的 HIV/AIDS 患者人数也在逐年累加。在 HIV/AIDS 患者长期的服药过程中, 药物不良反应、工作繁忙、CD4、患者自我管理能力低、经济条件等各种原因, 导致患 者出现依从性不良 , 患者退出的发生率髙。中国遏制与防治艾滋病要求 HIV/AIDS 患者 ART 治疗覆盖率是90%以上, 退出已经成为影响ART治疗覆盖率的最大威胁。本文就 HIV/AIDS 患者 ART 退出相关影响因素进行综述, 全面了解 HIV/AIDS 患者ART治疗可能退出的原因以及提供减少 HIV/AIDS 患者ART治疗停药和失访相关措施。
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
13927
期刊介绍: China Tropical Medicine, was approved by the Ministry of Science and Technology in 2001, is the only tropical medicine periodical under the charge of the National Health Commission of China. It’s organized by Hainan Provincial Center for Disease Prevention and Control, and Chinese Preventive Medicine Association. The journal is indexed by the following database: Scopus database, Embase database, EBSCO Database, The Western Pacific Region index medicus (WPRIM), American Chemical Abstracts (CA), International Centre for Agricultural and Biological Sciences Research Database (CABI), Global Health Database, Database of the Ulrich's Periodicals Directory, China Science and Technology Core Journals, China Core Journals (Selection) Database, Database of Chinese Biomedical Literature, Comprehensive Evaluation Database of Chinese Academic Journals, CAJCD Code of Conduct Excellent Journal, Database of Chinese SCI-Tech Periodicals, China Journal Full Text Database.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信